I reported previously (many times) on Israeli companies developing cancer treatments targeting individuals rather than specific areas of the body. Now, Israeli biotech Ayala is partnering with Bristol-Myers Squibb to develop treatments for cancer patients known to have a gene mutation.
Personalized cancer treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.